Syndax Pharmaceuticals, Inc. (SNDX)

Syndax Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	133.02	295.39	74.36	221.97	115.24	24.61
Short-Term Investments	273.38	282.19	410.04	224.87	182.51	36.46
Cash & Short-Term Investments	406.4	577.58	484.4	446.83	297.75	61.07
Cash Growth	8.71%	19.24%	8.41%	50.07%	387.54%	-25.13%
Other Receivables	4.69	1.23	4.06	0.43	0.2	0.53
Receivables	4.69	1.23	4.06	0.43	0.2	0.53
Inventory	-	-	-	-	0.06	0.17
Prepaid Expenses	3.51	2	1.22	0.87	0.43	0.21
Restricted Cash	-	-	-	0.12	0.12	-
Other Current Assets	0.22	0.06	0.12	0.15	0.32	0.35
Total Current Assets	414.81	580.88	489.79	448.4	298.86	62.33
Property, Plant & Equipment	0.76	1.5	1.06	1.26	0.48	1
Long-Term Investments	10.03	29.83	5.47	-	-	-
Other Long-Term Assets	0.22	0.68	0.92	-	1.27	0.2
Total Assets	425.81	612.88	497.24	449.66	300.61	63.53
Accounts Payable	4.9	9.96	4.35	5.67	3.51	6.18
Accrued Expenses	47.91	38.97	23.67	12.76	11.25	10.2
Current Portion of Long-Term Debt	-	-	-	-	2.29	-
Current Portion of Leases	0.85	1.05	0.44	0.36	0.32	0.48
Current Unearned Revenue	-	-	-	-	1.52	1.52
Other Current Liabilities	5.71	8.12	0.6	1.89	-	-
Total Current Liabilities	59.38	58.1	29.07	20.68	18.87	18.37
Long-Term Debt	-	-	-	19.9	17.83	-
Long-Term Leases	0	0.59	0.72	0.71	0.1	0.42
Long-Term Unearned Revenue	-	-	-	-	11.62	13.13
Other Long-Term Liabilities	-	-	-	-	0	0.01
Total Liabilities	59.38	58.68	29.79	41.29	48.43	31.93
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	1,493	1,456	1,161	952.02	820.82	527.07
Retained Earnings	-1,127	-902.4	-693.04	-543.7	-568.63	-495.47
Comprehensive Income & Other	0.37	0.22	-0.81	0.05	-0	-
Total Common Equity	366.43	554.2	467.45	408.37	252.19	31.6
Shareholders' Equity	366.43	554.2	467.45	408.37	252.19	31.6
Total Liabilities & Equity	425.81	612.88	497.24	449.66	300.61	63.53
Total Debt	0.85	1.64	1.16	20.97	20.54	0.9
Net Cash (Debt)	405.54	575.95	483.24	425.86	277.21	60.18
Net Cash Growth	9.03%	19.19%	13.47%	53.62%	360.68%	-26.23%
Net Cash Per Share	4.94	8.18	7.95	7.94	6.71	1.97
Filing Date Shares Outstanding	85.36	84.97	68.44	55.01	48.24	30.24
Total Common Shares Outstanding	85.57	84.83	68.11	54.98	47.88	27.14
Working Capital	355.43	522.78	460.72	427.71	279.99	43.96
Book Value Per Share	4.28	6.53	6.86	7.43	5.27	1.16
Tangible Book Value	366.43	554.2	467.45	408.37	252.19	31.6
Tangible Book Value Per Share	4.28	6.53	6.86	7.43	5.27	1.16
Machinery	-	0.25	0.25	0.54	0.41	0.41
Leasehold Improvements	-	0.17	0.17	0.17	0.17	0.17

Source: S&P Capital IQ. Standard template. Financial Sources.